SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-12-028164
Filing Date
2012-05-11
Accepted
2012-05-11 17:20:26
Documents
5
Period of Report
2012-05-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT v313017_8k.htm 8-K 21041
2 FORM OF NOTE AND COMMON STOCK SUBSCRIPTION AGREEMENT v313017_ex10-1.htm EX-10.1 74369
3 FORM OF SECURED PROMISSORY NOTE, DUE JUNE 30, 2012 v313017_ex10-2.htm EX-10.2 35301
4 PRESS RELEASE OF GENESIS BIOPHARMA, INC. ISSUED MAY 7, 2012 v313017_ex99-1.htm EX-99.1 5978
5 GRAPHIC image_001.jpg GRAPHIC 4210
  Complete submission text file 0001144204-12-028164.txt   143963
Mailing Address 1601 N. SEPULVEDA BLVD., #632 MANHATTAN BEACH CA 90266
Business Address 1601 N. SEPULVEDA BLVD., #632 MANHATTAN BEACH CA 90266 866-963-2220
Genesis Biopharma, Inc (Filer) CIK: 0001425205 (see all company filings)

IRS No.: 753254381 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-53127 | Film No.: 12835744
SIC: 4731 Arrangement of Transportation of Freight & Cargo